Furthermore, in AD patients, hippocampal CX3CL1 mRNA levels were markedly lower at the late stage of the disease (Braak-Tau stages V-VI) as compared to the intermediate one (Strobel et al. 2015). The gene discussed is CX3CL1; the disease is Alzheimer disease.